Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Céline Dubath

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 28, 2017
Aptamer-based liposomes improve specific drug loading and releaseKevin Plourde, Rabeb Mouna Derbali, Arnaud Desrosiers, et al.
Revue Medicale Suisse|September 20, 2023
[Antipsychotic prescribing in adults : what to watch out for ?]Carole Grandjean, Frederik Vandenberghe, Céline Dubath, et al.
Basic & Clinical Pharmacology & Toxicology|March 18, 2021
Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric populationAurélie Delacrétaz, Anaïs Glatard, Céline Dubath, et al.
Clinical Epigenetics|December 28, 2019
Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patientsAurélie Delacrétaz, Anaïs Glatard, Céline Dubath, et al.
Clinical Pharmacokinetics|September 26, 2019
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic AnalysesAnaïs Glatard, Monia Guidi, Aurélie Delacrétaz, et al.
The Journal of Clinical Psychiatry|April 19, 2019
Lipid Disturbances in Adolescents Treated With Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset HypercholesterolemiaAurélie Delacrétaz, Frederik Vandenberghe, Anaïs Glatard, et al.
The Journal of Clinical Psychiatry|May 13, 2022
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort StudyMarianna Piras, Céline Dubath, Mehdi Gholam, et al.
Pharmacopsychiatry|August 13, 2021
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort StudyCéline Dubath, Marianna Piras, Mehdi Gholam, et al.
Clinical and Translational Science|August 13, 2021
Metabolomic alteration induced by psychotropic drugs: Short-term metabolite profile as a predictor of weight gain evolutionMarie Lenski, Jonathan Sidibé, Mehdi Gholam, et al.
Clinical Epigenetics|February 28, 2024
DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational studyCéline Dubath, Eleonora Porcu, Aurélie Delacrétaz, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 28, 2017
Aptamer-based liposomes improve specific drug loading and releaseKevin Plourde, Rabeb Mouna Derbali, Arnaud Desrosiers, et al.
Revue Medicale Suisse|September 20, 2023
[Antipsychotic prescribing in adults : what to watch out for ?]Carole Grandjean, Frederik Vandenberghe, Céline Dubath, et al.
Basic & Clinical Pharmacology & Toxicology|March 18, 2021
Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric populationAurélie Delacrétaz, Anaïs Glatard, Céline Dubath, et al.
Clinical Epigenetics|December 28, 2019
Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patientsAurélie Delacrétaz, Anaïs Glatard, Céline Dubath, et al.
Clinical Pharmacokinetics|September 26, 2019
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic AnalysesAnaïs Glatard, Monia Guidi, Aurélie Delacrétaz, et al.
The Journal of Clinical Psychiatry|April 19, 2019
Lipid Disturbances in Adolescents Treated With Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset HypercholesterolemiaAurélie Delacrétaz, Frederik Vandenberghe, Anaïs Glatard, et al.
The Journal of Clinical Psychiatry|May 13, 2022
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort StudyMarianna Piras, Céline Dubath, Mehdi Gholam, et al.
Pharmacopsychiatry|August 13, 2021
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort StudyCéline Dubath, Marianna Piras, Mehdi Gholam, et al.
Clinical and Translational Science|August 13, 2021
Metabolomic alteration induced by psychotropic drugs: Short-term metabolite profile as a predictor of weight gain evolutionMarie Lenski, Jonathan Sidibé, Mehdi Gholam, et al.
Clinical Epigenetics|February 28, 2024
DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational studyCéline Dubath, Eleonora Porcu, Aurélie Delacrétaz, et al.
Pageof 3